Clenbuterol Sopharma was initially engineered as a bronchodilator to alleviate asthma and COPD in humans outside the United States and is veterinary prescribed elsewhere. It relaxes smooth bronchial muscles to facilitate breathing and raises the basal metabolic rate, supporting thermogenesis—amplifying calorie burning and fat mobilization. It may preserve lean muscle mass during calorie-restricted phases. Commonly, it is clinically prescribed for asthma management in countries where approved and frequently used without a prescription during cutting cycles, typically by athletes and bodybuilders seeking to reduce weight.